ArticleTranslational cancer research2026
Development and validation of machine learning models for predicting synchronous lung metastasis in United States colorectal cancer patients: a SEER database analysis.
Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Colorectal cancer lung metastases (CRCLM) significantly influence treatment planning and prognosis in colorectal cancer (CRC). This study aimed to develop and validate machine learning-based models to support individualized risk stratification for chest computed tomography (CT) utilization during baseline evaluation by predicting synchronous CRCLM at diagnosis. Methods: Patients with primary CRC diagnosed between 2010 and 2015 were identified from the Surveillance, Epidemiology, and End Results (SEER) database using International Classification of Diseases for Oncology, 3 Results: Among 51,553 patients, 1,329 (2.6%) had synchronous CRCLM. In the validation cohort, the area under the curve was 0.81 for XGB, 0.81 for RF, 0.79 for DT, and 0.73 for LR after hyperparameter optimization. Calibration curves indicated high consistency between predictions and observations. DCA revealed substantial clinical utility for all models. SHAP analysis highlighted CEA and N stage as the strongest predictors in the RF model, while CEA and T stage were most influential in the XGB model. Conclusions: Machine learning models, particularly XGB and RF, demonstrated robust performance in predicting synchronous CRCLM. CEA was consistently identified as the most important risk factor, supporting personalized chest CT utilization during initial CRC staging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.